Abbott Laboratories (NYSE:ABT)

86.35
Delayed Data
As of Dec 13
 +0.38 / +0.44%
Today’s Change
65.44
Today|||52-Week Range
88.76
+19.38%
Year-to-Date
Is Abbott Laboratories Stock a Buy?
Dec 08 / MotleyFool.com - Paid Partner Content
Despite the Naysayers, AbbVie Keeps Marching On
Dec 03 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close85.97
Today’s open85.78
Day’s range85.78 - 86.71
Volume3,872,210
Average volume (3 months)4,507,948
Market cap$152.8B
Data as of 6:30pm ET, 12/13/2019

Growth & Valuation

Earnings growth (last year)+397.55%
Earnings growth (this year)+12.59%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+11.64%
P/E ratio46.9
Price/Sales4.19
Price/Book4.97

Competitors

 Today’s
change
Today’s
% change
BDXBecton Dickinson and...+3.28+1.24%
BSXBoston Scientific Co...+0.42+0.94%
BAXBaxter International...+0.45+0.54%
ZBHZimmer Biomet Holdin...+0.66+0.45%
Data as of 6:30pm ET, 12/13/2019

Financials

Next reporting dateJanuary 24, 2020
EPS forecast (this quarter)$0.95
Annual revenue (last year)$30.6B
Annual profit (last year)$2.4B
Net profit margin7.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Abbott Park, Illinois

Forecasts